Please use this identifier to cite or link to this item:
https://scidar.kg.ac.rs/handle/123456789/12639
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.rights.license | openAccess | - |
dc.contributor.author | Muric, Nemanja | - |
dc.contributor.author | Arsenijevic, Nebojsa | - |
dc.contributor.author | Borovcanin, Milica | - |
dc.date.accessioned | 2021-04-20T21:21:26Z | - |
dc.date.available | 2021-04-20T21:21:26Z | - |
dc.date.issued | 2020 | - |
dc.identifier.uri | https://scidar.kg.ac.rs/handle/123456789/12639 | - |
dc.rights | info:eu-repo/semantics/openAccess | - |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.source | Frontiers in Psychiatry | - |
dc.title | Chlorpromazine as a Potential Antipsychotic Choice in COVID-19 Treatment | - |
dc.type | article | - |
dc.identifier.doi | 10.3389/fpsyt.2020.612347 | - |
dc.identifier.scopus | 2-s2.0-85099047453 | - |
Appears in Collections: | Faculty of Medical Sciences, Kragujevac |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
10.3389-fpsyt.2020.612347.pdf | 163.61 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License